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Background: Angiogenesis plays a crucial role in development, wound healing as well as tumour growth and
metastasis. Although the general implication of the cytoskeleton in angiogenesis has been partially unravelled, little
is known about the specific role of actin isoforms in this process. Herein, we aimed at deciphering the function of
γ-actin in angiogenesis.
Methods: Localization of β- and γ-actin in vascular endothelial cells was investigated by co-immunofluorescence
staining using monoclonal antibodies, followed by the functional analysis of γ-actin using siRNA. The impact of
γ-actin knockdown on the random motility and morphological differentiation of endothelial cells into vascular
networks was investigated by timelapse videomicroscopy while the effect on chemotaxis was assessed using
modified Boyden chambers. The implication of VE-cadherin, VEGFR-2 and ROCK signalling was then examined by
Western blotting and using pharmacological inhibitors.
Results: The two main cytoplasmic isoforms of actin strongly co-localized in vascular endothelial cells, albeit with
some degree of spatial preference. While β-actin knockdown was not achievable without major cytotoxicity, γ-actin
knockdown did not alter the viability of endothelial cells. Timelapse videomicroscopy experiments revealed that
γ-actin knockdown cells were able to initiate morphological differentiation into capillary-like tubes but were unable
to maintain these structures, which rapidly regressed. This vascular regression was associated with altered regulation
of VE-cadherin expression. Interestingly, knocking down γ-actin expression had no effect on endothelial cell
adhesion to various substrates but significantly decreased their motility and migration. This anti-migratory
effect was associated with an accumulation of thick actin stress fibres, large focal adhesions and increased
phosphorylation of myosin regulatory light chain, suggesting activation of the ROCK signalling pathway.
Incubation with ROCK inhibitors, H-1152 and Y-27632, completely rescued the motility phenotype induced by
γ-actin knockdown but only partially restored the angiogenic potential of endothelial cells.
Conclusions: Our study thus demonstrates for the first time that β-actin is essential for endothelial cell survival
and γ-actin plays a crucial role in angiogenesis, through both ROCK-dependent and -independent mechanisms.
This provides new insights into the role of the actin cytoskeleton in angiogenesis and may open new therapeutic
avenues for the treatment of angiogenesis-related disorders.
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Angiogenesis is defined as the formation of new blood
vessels from pre-existing ones. It is crucial for organ
growth during development but also throughout adult
life to repair wounded tissues. Furthermore, an imbal-
ance in this process directly contributes to numerous
pathologies such as cancer, diabetes, age-related macular
degeneration, ischemic disorders and rheumatoid arth-
ritis [1,2]. The multi-step and complex process leading
to the formation of a new vascular network relies on the
activation of endothelial cells followed by their prolifera-
tion, migration and morphological differentiation into
capillary tubes. The cytoskeleton which directly regulates
and controls an impressive array of cell functions, in-
cluding cell shape maintenance, cell division, vesicle and
organelle transport, cell motility and differentiation,
plays a major role in angiogenesis. Studies focusing on
the anti-angiogenic properties of microtubule-targeting
drugs – reviewed by Pasquier et al. [3] – have provided
major insights into the role of microtubules in this
process. However, very little is known about the specific
role of actin isoforms in angiogenesis.
In vertebrates, there are 6 functional actin genes and
the expression of the six actin isoforms is regulated both
spatially and temporally in a tissue-specific manner. Four
of these isoforms (i.e. α-cardiac muscle actin, α-skeletal
muscle actin, α-smooth muscle actin and γ-smooth
muscle actin) are mainly expressed in muscle cells, while
the cytoplasmic isoforms β- and γ-actin are ubiquitous
[4]. Interestingly, the β- and γ-actin isoforms are almost
identical proteins, differing only by 4 amino acid resi-
dues at the N-terminal end (positions 1, 2, 3 and 9). Dis-
tinct localization of β- and γ-actin mRNAs in several
cell types, such as neurons, myoblasts and osteoblasts,
has suggested for almost 20 years a spatial segregation of
the two isoforms [5,6]. However, the spatial and func-
tional segregation of β- and γ-actin was confirmed only
recently in fibroblasts and epithelial cells by Chaponnier
and colleagues, using newly developed monoclonal anti-
bodies [7]. In particular, β-actin appears to play a role in
cell attachment and contraction by preferentially localiz-
ing to stress fibres whereas γ-actin is mainly organised
as a meshwork in cortical and lamellipodial structures
and thus plays a crucial role in cell motility [7]. In ac-
cordance with this finding, we recently demonstrated
that γ-actin specifically regulates cell motility by modu-
lating the Rho-associated kinase (ROCK) signalling path-
way and therefore influencing the phosphorylation of
focal adhesion protein paxillin and myosin regulatory
light chain 2 in neuroblastoma cells [8]. Elsewhere, key
functional differences between β- and γ-actin were also
recently revealed by mouse knock-out experiments. In-
deed, β-actin knock-out mice are not viable, in part due
to severe growth and migration defects of β-actin nullembryonic cells, which are not observed in γ-actin null
embryonic cells [9]. In contrast, γ-actin knock-out mice
are viable, despite suffering increased mortality at birth
and progressive hearing loss, which suggests that γ-actin
is required for cytoskeleton maintenance but not for
development [10]. Spatial segregation and functional dif-
ferences led us to hypothesize that β- and γ-actin may
play distinct roles in endothelial cells and differentially
contribute to angiogenesis. We therefore investigated
the localization of β- and γ-actin in vascular endothelial
cells and undertook the functional analysis of γ-actin
by RNAi to decipher its specific function in endothe-
lial cell adhesion, motility and morphological differen-




HMEC-1 endothelial cells were originally isolated from
dermal microvessels and immortalized by transfection
with SV40 large T antigen [11]. They were obtained from
the Cell Culture Laboratory in the Hôpital de la
Conception (Assistance Publique Hôpitaux de Marseille,
Marseille, France) and grown in MCDB-131 medium
(Invitrogen, Mount Waverley, Australia) containing 10%
heat-inactivated Fetal Calf Serum (FCS), 2 mM L-glutam-
ine, 1% penicillin and streptomycin, 1 μg/mL hydrocorti-
sone and 10 ng/mL epithelial growth factor (BioScientific,
Gymea, Australia). BMH29L cells are bone marrow de-
rived endothelial cells that were immortalized by ectopic
expression of human telomerase reverse transcriptase
[12]. They were kindly provided by Dr Karen MacKenzie
(Children’s Cancer Institute Australia) and grown in
Medium 199 (Invitrogen) containing 10% heat-inactivated
FCS, 5% male human serum AB only (Sigma-Aldrich,
Castle Hill, Australia), 1% penicillin and streptomycin, 1%
heparin, 5 ng/mL recombinant human FGFβ (fibroblast
growth factor β; Sigma-Aldrich) and 20 μg/mL Endothelial
Cell Growth Factor (ECGF; Roche, Dee Why, Australia).
Both cell lines were routinely maintained in culture on
0.1% gelatin-coated flasks at 37°C and 5% CO2. Cell lines
were regularly screened and are free from mycoplasma
contamination.
Gene silencing
γ-actin gene expression was silenced in endothelial cells
using the siRNA sequence previously described (5′-
AAGAGATCGCCGCGCTGGTCA-3′; Qiagen, Doncas-
ter, Australia) [13]. An alternative siRNA sequence (5′-
CAGCAACACGTCATTGTGTAA-3′; Qiagen) was also
used in confirmation experiments [8]. β-actin gene
expression was targeted using the siRNA sequence previ-
ously described (5′-AATGAAGATCAAGATCATTGC-3′;
Qiagen) [14]. The optimum amount of siRNA was
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BMH29L cells, respectively and was used in all subse-
quent experiments. A non-silencing control siRNA,
which has no sequence homology to any known hu-
man gene sequence, was used as a negative control in
all experiments (Qiagen). Cells were transfected using
the Nucleofector® II device (Lonza, Mount Waverley,
Australia) as previously described [15]. Briefly, HMEC-1
and BMH29L cells were resuspended in nucleofector® so-
lution R and V, respectively, and transfected with siRNA
using specifically optmized nucleofector® programs (T-016
and S-003 for HMEC-1 and BMH29L, respectively). All
subsequent experiments were performed 72 h after siRNA
transfection, when the level of γ-actin protein expression
was the lowest.
Quantitative RT-PCR
The expression of γ-actin mRNA was examined using
quantitative RT-PCR. Total RNA was extracted and
DNase treated using the Qiagen RNeasy Plus kit according
to the manufacturer’s instructions (Qiagen) and cDNA
synthesis was performed using High capacity cDNA
reverse transcription kit with RNAse inhibitor (Applied
Biosystems, Mulgrave, Australia). Real-time PCR was
performed on 7900HT Fast Real-time PCR system
using the TaqMan® gene expression Master Mix (Ap-
plied Biosystems). γ-actin mRNA primer and probe
sequences used were as follows: forward, 5′-CAG
CTCTCGCACTCTGTTCTTC-3′; reverse, 5′-ACATG
CCGGAGCCATTGT-3′; probe, 5′-CGCGCTGGTCA
TT-3′. All data were normalized to the housekeeping
gene Ppia (peptidilprolyl isomerase A, TaqMan® En-
dogenous Control, Applied Biosystems). Gene expres-
sion levels were determined using the ΔΔCt method,
normalized to the housekeeper gene and expressed
relative to a calibrator [16].
Western blotting analysis
For western blotting analysis, cells were lysed in RIPA
buffer containing a cocktail of protease and phosphatase
inhibitors (Sigma-Aldrich). Equal amounts of protein
(10–15 μg) were resolved on 12% sodium dodecyl sulfate
polyacrylamide gel electrophoresis or 4-15% pre-cast
Criterion acrylamide gels (Bio-Rad Laboratories, Glades-
ville, Australia) before electrotransfer onto nitrocellulose
membrane. Immunoblotting was performed using anti-
bodies directed against β-actin (clone AC-74, Sigma-
Aldrich), γ-actin – courtesy of Pr Peter Gunning [17],
GAPDH (Abcam, Cambridge, UK), phospho-myosin
light chain 2 (Cell Signaling Technology, Beverly, MA,
USA), VE-cadherin (Cell signaling technology) and
VEGFR-2 (Cell signaling technology). The membranes
were then incubated with horseradish peroxidase-
conjugated IgG secondary antibodies and protein detectedwith ECL Plus (GE Healthcare Life Sciences, Uppsala,
Sweden). The blots were scanned and densitometric ana-
lysis performed as previously described [13].
Immunofluorescence staining
Vascular endothelial cells were seeded on gelatin-coated
8-well Permanox Lab-Tek chamber slides (Applied Bio-
systems) after siRNA transfection. β-actin and γ-actin
were stained as previously described [7] with slight mod-
ifications. Specifically, cells were fixed with 3.7% formal-
dehyde for 20 min at RT and permeabilized with 100%
methanol for 20 min at −20°C. Cells were incubated with
the following primary mAbs: anti-β-actin (mAb 4C2,
IgG1 – courtesy of Pr Christine Chaponnier [7]) and
anti-γ-actin (mAb 2A3, IgG2b – courtesy of Pr Christine
Chaponnier [7]). The following secondary Abs were
used: FITC-conjugated goat anti-mouse IgG1 (Southern
Biotechnology, Birmingham, AL) and TRITC-conjugated
goat anti-mouse IgG2b (Southern Biotechnology). For
tubulin staining, cells were fixed and permeabilized in
100% methanol at 20°C for 15 min and blocked with
10% FCS for 30 min. Microtubules were then stained
with anti-βI-tubulin primary antibody (Abcam), followed
by Alexa Fluor 488 anti-mouse secondary antibody
(Invitrogen). For paxillin and phalloidin dual staining,
cells were fixed with 3.7% formaldehyde/PBS for 10 min
and permeabilized with 0.1% Triton X-100/PBS for
5 min. Focal adhesions were then stained with anti-
paxillin primary antibody (BD Biosciences), followed
by Alexa Fluor 488 anti-mouse secondary antibody
(Invitrogen) and Alexa 568-conjugated phalloidin
(Invitrogen). All slides were mounted on coverslips
with ProLong Gold anti-fade reagent containing DAPI
(Invitrogen) and imaged using the 63X oil-immersion
objective of an Axiovert 200 M fluorescent microscope
coupled to an AxioCamMR3 camera driven by the
AxioVision 4.8 software (Carl Zeiss, North Ryde,
Australia). The thickness of actin stress fibres was
determined performing a line scan perpendicular to the
fibres using Image J, while the size of paxillin-
containing adhesion sites was measured using the
AxioVision 4.8 software.
Colocalization analysis
Colocalization between β-actin and γ-actin channels was
assessed by measuring the Pearson’s Correlation Coeffi-
cient and visually inspecting two-dimensional histo-
grams (fluorograms). The Pearson’s coefficient measures
the linear relationship between the pixel intensities of two
channels. In the case of positive correlation this value can
drop either due to decreasing colocalization, or due to dif-
ferences in stoichiometry in structures. The fluorogram can
distinguish these two scenarios, low colocalization shows
by dispersion of points whilst varying stochiometries show
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using the Coloc 2 plugin in ImageJ (imagej.nih.gov/ij).
Image background was carefully subtracted from each
channel and regions of interest were drawn around each
cell to exclude extracellular pixels from the measurement.
Measurements were performed on single cells to ensure
variations in expression and staining did not contribute to
multiple stoichiometries.
Adhesion assay
For the adhesion assay, cells were pre-labeled in situ
with 10 μM Cell Tracker Green CMFDA (Invitrogen) in
serum-free medium for 30 min and 50,000 cells were
then seeded onto 24-well plates, pre-coated for 2 hours
at 37°C with various extra-cellular matrix (ECM) pro-
teins: fibronectin (2 μg/mL), laminin (10 μg/mL) or type
I collagen (10 μg/mL). After 1 hour incubation, cells
were washed twice with PBS and the number of adhered
cells was assessed with a Victor 3 plate reader (Perkin-
Elmer, Glen Waverley, Australia) at 492/517 (Abs/Em).
All readings were then normalized to the negative con-
trol (no ECM).
Chemotaxis assay
The chemotaxis assay was performed as previously de-
scribed [18]. Briefly, the underside of 8 μm transparent
polyethylene terephthalate membrane inserts (BD Fal-
con) was pre-coated with 0.1% gelatin for 1 h. The cells
were pre-labeled in situ with 10 μM Cell Tracker Green
CMFDA (Invitrogen) in serum-free medium for 30 min
and 100,000 cells were then seeded onto the insert in
assay medium (0.5% BSA in serum-free medium). Assay
medium supplemented with 5% FCS, 0.1 ng/mL VEGF-
A, 5 ng/mL FGFβ or 20 μg/mL ECGF was then added to
the bottom of the insert and used as chemoattractant. A
negative control was included in each experiment by
adding serum-free medium to the bottom of the insert.
The plates were incubated for 6 h at 37°C and 5% CO2.
Excess cells on the upper side of the insert were then
gently swabbed off with a cotton tip and migrated cells
at the underside of the insert were measured with the
same plate reader used for the adhesion assay. All
readings were then normalized to the negative control
(serum-free medium).
Random motility assay
Random cell motility was assessed by time-lapse micros-
copy as previously described [18]. Briefly, cells were
seeded on a 24-well gelatin-coated plate and allowed to
adhere for 1 h. Photographs were then taken every
5 min for 6 h in at least 2 view fields per well using the
5X objective of the same microscope device used for
immunofluorescence experiments. During this assay,
cells were constantly maintained at 37°C and 5% CO2.Analysis was performed using the tracking module of
the AxioVision 4.8 software. At least 25 cells per view
field were tracked for 6 h; cells undergoing division or
apoptosis were excluded from analyses. The persistent
random-walk model was used to characterize cell motil-
ity [19]. For each individual cell, the mean square






where di is the displacement of a cell from its initial
position at time level ti. The persistence time (P) (i.e.
average time interval between significant movements
and direction changes) and random motility coefficient
(μ) (i.e. the rate at which a cell population is able to mi-
grate into and colonize a new area) were deduced from
the < D2 > value and the cell velocity (S), using the fol-
lowing formulas:
< D >¼ 2S2P2 1=Pð Þ−1þ exp −1=Pð Þ½ 
μ ¼ 1=2ð ÞS2P
Wound healing assay
An optimized wound healing assay was used as previ-
ously described [20], with slight modifications. Endothe-
lial cells were grown to confluence in specific culture
inserts (Ibidi, Martinsried, Germany). After 24 h, the
culture inserts were removed, leaving a definite cell-free
gap of approximately 400 μm, and the cells were washed
with PBS before their incubation in culture medium.
The colonization of the cell-free gap was analysed by
time-lapse videomicroscopy using the 5X objective of
the same microscope device used for immunofluores-
cence experiments. Photographs were taken every 10 mi-
nutes for 20 h and plates were kept at 37°C and 5% CO2
throughout the duration of the experiment. The migra-
tion rate was calculated digitally by quantification of the
cell-free area at the different time points using the Axio-
Vision 4.7 software.
In vitro Matrigel™ assay
Matrigel™ (BD Biosciences, North Ryde, Australia) assay
was used to determine the effect of γ-actin knockdown
on endothelial cell morphogenesis into capillary tubes,
as previously described [18]. Briefly, 24-well plates were
coated at 4°C with 270 μL of a Matrigel™ solution (1:1
dilution in culture medium), which was then allowed to
solidify for 1 h at 37°C before cell seeding. Cells were
allowed to undergo morphogenesis and form capillary-
like structures and photographs were taken after 8 h
using the 5X objective of the same microscope device
used for immunofluorescence experiments. Angiogenesis
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surface area of capillary tubes formed in at least 10 view
fields per well using the AxioVision 4.7 software.
A non-enzymatic methodology was also established to
analyse the potential changes in protein expression that
occur during the morphological differentiation of endo-
thelial cells into vascular networks. Briefly, 3.2 × 105
cells were seeded onto 6-well plates previously coated
with Matrigel™ and harvested at different time points of
the morphological differentiation process (i.e. 15 min, 1,
2, 4 and 8 h). Cells were first incubated with a Cell Re-
covery Solution (BD Biosciences) for 1 h at 4°C under
agitation to allow complete dissolution of the Matrigel™,
then pelleted, washed with cold PBS and finally lysed as
described in the western blotting section.
Rho-associated kinase (ROCK) signalling inhibition
ROCK signalling was interrupted as previously described
[8], through the use of two specific ROCK inhibitors, H-
1152 (Merck Millipore, Kilsyth, Australia) and Y-27632
(Sigma-Aldrich). Stock solutions of both inhibitors were
prepared in water and stored at 4°C. Inhibitors (1–10 μM)Figure 1 Localization of β- and γ-actin in vascular endothelial cells. Re
endothelial cells stained with β-actin (top) and γ-actin (middle) antibodies. T
red and DNA (DAPI) in blue. Scale bar, 20 μm.were added to siRNA-transfected cells at 48 h post-
transfection, and remained in culture medium for a fur-
ther 24 h and during wound-healing and angiogenesis
assays.
Statistical analysis
All experiments were performed at least in triplicate.
Statistical significance was determined using two-sided
student’s t test in the GraphPad Prism 4 software
(GraphPad Software, Inc).
Results
Spatial distribution of β- and γ-actin in vascular endothelial
cells
Using specific monoclonal antibodies directed against β-
and γ-actin [7], we investigated the cellular distribution
of both actin isoforms in two models of vascular endo-
thelial cells (Figure 1). These co-immunofluorescence
experiments demonstrated extensive colocalization of
the two actin isoforms with some level of spatial prefer-
ence. In HMEC-1 and BMH29L endothelial cells, β- and
γ-actin signals strongly overlapped but β-actin signalpresentative photographs of HMEC-1 (left) and BMH29L (right)
he merged photographs (bottom) show β-actin in green, γ-actin in
Figure 2 γ-actin knockdown in vascular endothelial cells. (A)
Histogram showing γ-actin relative gene expression following treatment
with control (white) and γ-actin siRNA (black) for 24 h as assessed
by quantitative RT-PCR. β2-microglobulin was used as housekeeping
gene. Columns, means of at least three individual experiments; bars, SE.
Statistics were calculated by comparing γ-actin relative expression
in control and γ-actin siRNA-treated HMEC-1 cells; **, p < 0.01. (B)
Representative immunoblots of HMEC-1 (left) and BMH29L (right) cell
lysates following treatment with control and γ-actin siRNA for 72 h.
Membranes were probed with anti-β-actin, anti-γ-actin and anti-GAPDH
(loading control) antibodies. (C) Histogram showing the relative protein
expression γ-actin as determined by densitometry after normalization
with GAPDH, following treatment with control (white) and γ-actin siRNA
(black) for 72 h. Columns, means of at least four individual experiments;
bars, SE. Statistics were calculated by comparing γ-actin expression level
in control and γ-actin siRNA-treated cells; ***, p < 0.001.
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and membrane ruffling in relation to γ-actin, which was
more uniformly spread across the entire microfilament
meshwork. Quantification using the Pearson’s Correlation
Coefficient method [21] confirmed the strong colocaliza-
tion of β- and γ-actin (Additional file 1: Figure S1A). Fur-
thermore, decreased correlation in some cells was mostly
due to variations in stoichiometry in different subcellular
structures rather than complete segregation of the two
actin isoforms (Additional file 1: Figure S1B).
Knockdown of cytoplasmic γ-actin expression by RNAi
Significant knockdown of β-actin expression could not
be achieved in endothelial cells without major cytotox-
icity (data not shown). We therefore focused our atten-
tion on the functional analysis of γ-actin using RNA
interference. As shown in Figure 2A, when HMEC-1
cells were transfected with γ-actin siRNA for 24 h, a 71
± 12% reduction in γ-actin gene expression was observed
by quantitative RT-PCR (p < 0.01). Consistently, a 50-
60% knockdown of γ-actin expression was observed at
the protein level after 72 h transfection in both HMEC-1
and BMH29L cells (Figure 2B and C; p < 0.001). Western
blot analysis also showed that this level of γ-actin knock-
down could be achieved without any significant compen-
satory changes in β-actin expression.
Co-immunofluorescence staining was then used to ana-
lyse the effects of γ-actin knockdown on the localization of
actin isoforms. In γ-actin siRNA-treated HMEC-1 cells,
qualitative data revealed that the dense cortical actin mesh-
work was partially depleted in γ-actin and the remaining
γ-actin was mostly found in stress fibres (Figure 3). In
contrast, β-actin distribution was unaltered. Similar
effects were observed in BMH29L cells (Additional
file 2: Figure S2). Interestingly, quantitative analysis
showed that γ-actin knockdown resulted in a slight
increase in correlation of the β- and γ-actin signals,
which was mostly due to decreased variation in stoichiom-
etry (Additional file 1: Figure S1; Pearson coefficient of
0.75 ± 0.02 and 0.86 ± 0.01 in control and γ-actin siRNA-
treated cells, respectively; p < 0.001).
Cytoplasmic γ-actin expression is essential for the
morphological differentiation of endothelial cells into
vascular networks
Matrigel™ assay was used to investigate the role of γ-
actin in angiogenesis in vitro. Photographs taken after
8 hour incubation on Matrigel™ revealed that knocking
down γ-actin expression almost completely suppressed
the formation of capillary-like structures (Figure 4A).
Quantitative analysis showed that γ-actin knockdown
inhibited the morphological differentiation of HMEC-1
and BMH29L cells by 89.5 ± 2.7% and 72.0 ± 6.7%, re-
spectively (Figure 4B; p < 0.001). Similar results wereobtained when HMEC-1 cells were transfected for 72 h
with a different γ-actin siRNA sequence (Additional file
3: Figure S3). Time-lapse videomicroscopy experiments
revealed that γ-actin siRNA-treated cells initiated the
Figure 3 Effect of γ-actin knockdown on the localization of β- and γ-actin. Representative photographs of HMEC-1 endothelial cells treated
for 72 h with control (left) or γ-actin siRNA (right) and stained with β-actin (top) and γ-actin (middle) antibodies. The merged photographs (bottom)
show β-actin in green, γ-actin in red and DNA (DAPI) in blue. Scale bar, 20 μm.
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not maintain these vascular networks, which rapidly
regressed (Additional file 4: supplementary videos 1–2).
This demonstrates that γ-actin is dispensable in the
early steps of angiogenesis but required for neovessel
maintenance.
Vascular regression induced by γ-actin knockdown is
associated with impaired VE-cadherin up-regulation
Endothelial cells were harvested non-enzymatically at
different time points of the morphological differentiation
process on Matrigel™ (Figure 5A) to investigate potential
changes in expression of γ-actin, endothelial cell-to-cell
contact protein VE-cadherin and major angiogenesis
receptor VEGFR-2 by western blotting. While there was
no significant change in γ-actin expression during the mor-
phological differentiation of endothelial cells, VE-cadherin
expression was gradually up-regulated (Figure 5B).
Densitometry analysis revealed a 5-fold increase inVE-cadherin relative expression in control siRNA-
treated cells between 15 min and 8 h incubation on
Matrigel™ (Figure 5C; p < 0.001). Interestingly, γ-actin
knockdown significantly impaired VE-cadherin up-
regulation (Figure 5B and C). Although there was no
significant difference in VE-cadherin expression be-
tween control siRNA- and γ-actin siRNA-treated
cells at steady state when cells were grown on plastic
(Additional file 5: Figure S4A), the levels of VE-
cadherin expression were significantly lower in γ-actin
siRNA-treated cells at all time points of the morpho-
logical differentiation process on Matrigel™ except at
4 h (Figure 5C). Additional western blot analysis further
revealed that the expression of VEGFR-2 was also up-
regulated during morphological differentiation, but this
up-regulation was not affected by γ-actin knockdown
(Additional file 5: Figure S4B). This suggests that the up-
regulation of VE-cadherin expression, but not VEGFR-2,
is dependent upon adequate γ-actin expression.
Figure 4 Effect of γ-actin knockdown on the formation vascular networks in vitro. (A) Representative photographs of HMEC-1 (left) and
BMH29L cells (right) incubated for 8 h on Matrigel™. Cells were treated either with control (top) or γ-actin siRNA (bottom) for 72 h. Scale bar,
250 μm. (B) Histogram showing the surface occupied by vascular networks following treatment with control (white) and γ-actin siRNA (black) for
72 h. Columns, means of at least four individual experiments; bars, SE. Statistics were calculated by comparing the mean surface occupied by
vascular networks per view field (at least 10 view fields per condition) for control siRNA- and γ-actin siRNA-treated cells. ***, p < 0.001.
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motility and chemotaxis
To investigate the effects of γ-actin knockdown on the
pro-angiogenic functions of endothelial cells, a panel of
cell biology assays was used. First, we found that knock-
ing down γ-actin expression did not significantly affect
the adhesion of endothelial cells to various substrates,
including major ECM proteins fibronectin, laminin and
collagen I (Figure 6A). In contrast, knocking down γ-
actin expression significantly impaired the chemotactic re-
sponse of endothelial cells to various chemo-attractants.
As shown in Figure 6B, addition of FCS, VEGF, FGFβ
or ECGF in the bottom well of the Boyden chamber
resulted in a significant increase in migration of con-
trol siRNA-treated HMEC-1 cells, as compared to the
negative control (absence of FCS; p < 0.05). This in-
crease in cell migration was significantly inhibited
when HMEC-1 cells were transfected with γ-actin
siRNA (p < 0.05). Interestingly, FGFβ-induced migra-
tion was completely suppressed by γ-actin knockdown,
while migration induced by other chemo-attractants
was only partially reduced.The effect of γ-actin knockdown on the random motil-
ity of endothelial cells was then assessed by time-lapse
videomicroscopy experiments. Figure 6C shows the rep-
resentative trajectories of 5 cells transfected with either
control (left panel) or γ-actin siRNA (right panel).
While control siRNA-treated cells randomly explored
their micro-environment, γ-actin siRNA-treated cells
appeared to stay focused around the same area.
Analysis using the persistent random walk model [19]
revealed that γ-actin knockdown decreased the aver-
age cell velocity and increased the time endothelial
cells spent not moving as evidenced by an increase in
persistence time (Table 1). As a result, γ-actin knock-
down reduced the capacity of endothelial cells to ex-
plore their environment as shown by a decrease in
random motility coefficient (i.e. the rate at which a
cell will migrate into a new area and colonize it).
In order to further investigate the effects of γ-actin
knockdown on endothelial cell migration, wound healing
experiments were performed using time-lapse videomi-
croscopy. Figure 6D shows representative photographs
taken from control (top panel) and γ-actin siRNA-
Figure 5 Effect of γ-actin knockdown on VE-cadherin expression during morphological differentiation of endothelial cells into vascular
networks. (A) Representative photographs of HMEC-1 cells at various time points of the morphological differentiation process on Matrigel™,
following treatment with control (top) and γ-actin siRNA (bottom) for 72 h. Scale bar, 250 μm. (B) Representative immunoblots of HMEC-1 cell
lysates obtained at different time points of the morphological differentiation process on Matrigel™, following treatment with control and γ-actin
siRNA for 72 h. Membranes were probed with anti-VE-cadherin, anti-γ-actin and anti-GAPDH (loading control) antibodies. (C) Histogram showing
the relative protein expression of VE-cadherin as determined by densitometry after normalization with GAPDH (loading control), following
treatment with control (white) and γ-actin siRNA (black) for 72 h. Columns, means of at least four individual experiments; bars, SE. Statistics were
calculated by comparing VE-cadherin expression level in control and γ-actin siRNA-treated HMEC-1 cells; **, p < 0.01; ***, p < 0.001.
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time point, recovery from the wound was 93.0 ± 3.4%
and 67.2 ± 3.5% in control and γ-actin siRNA-treated
cells, respectively (p < 0.001). As shown in Figure 6E, γ-
actin knockdown resulted in a significant decrease in
wound recovery at all time points until 15 h. Linear re-
gression analysis showed that control siRNA-treated
BMH29L cells reached 50% wound recovery after 6.7 ±
0.4 h, whereas it took 9.4 ± 0.6 h (p < 0.01) to γ-actin
siRNA-treated BMH29L cells (data not shown). Similar
results were obtained with HMEC-1 cells, which took7.8 ± 0.5 h and 9.8 ± 0.5 h to reach 50% wound recovery
(p < 0.01), when they were transfected with control and
γ-actin siRNA, respectively (data not shown).
Cytoplasmic γ-actin regulates endothelial cell motility
through ROCK signalling pathway
In order to gain more insights into the role of γ-actin
in endothelial cell motility, we investigated potential
changes in the organisation of microtubules, actin stress
fibres and focal adhesions as a result of γ-actin knock-
down. Tubulin staining of endothelial cells showed no
Figure 6 Effect of γ-actin knockdown on cell adhesion, migration and motility. (A) Histogram showing the relative adhesion of endothelial
cells following treatment with control (white) and γ-actin siRNA (black) for 72 h. Fluorescently labeled HMEC-1 cells were allowed to adhere to
various substrates for 1 h. Columns, means of at least three individual experiments; bars, SE. (B) Histogram showing the relative migration of
endothelial cells towards FCS, VEGF, FGFβ and ECGF following treatment with control (white) and γ-actin siRNA (black) for 72 h. Fluorescently
labeled HMEC-1 cells were allowed to migrate through 8 μm pore PET membrane and towards a chemo-attractant for 6 h. Columns, means of at
least four individual experiments; bars, SE. Statistics were calculated by comparing the fluorescence measured at 492/517 (Abs/Em) with control
and γ-actin siRNA-treated cells; *, p < 0.05; **, p < 0.001. (C) Representative trajectories of 5 individual HMEC-1 cells, recorded by time-lapse
videomicroscopy over 6 h, following treatment with control (left) and γ-actin siRNA (right) for 72 h. Scale, −130 μm to +130 μm for both x and y
axes. (D) Representative photographs of control (top) and γ-actin siRNA-treated (bottom) BMH29L cells in wound healing experiments, taken 12 h
after start of experiment. Broken lines show the position of the initial cell-free gap (at time 0) and solid lines highlight the position of the
migration edge after 12 h. Inset, % of wound closure. (E) Graph showing the percentage of wound recovery as a function of time for control
(black, solid line) and γ-actin siRNA-treated (red, broken line) BMH29L cells. Points, means of at least four individual experiments; bars, SE. Statistics
were calculated by comparing control and γ-actin siRNA-treated cells at specific time points; *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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microtubule network as a result of γ-actin knock-
down (Additional file 6: Figure S5). In contrast, co-
immunofluorescence experiments with phalloidin andanti-paxillin antibody demonstrated that transfection
of endothelial cells with γ-actin siRNA led to an accumu-
lation of thick actin stress fibres and large paxillin-
containing focal adhesions (Figure 7A). Quantitative
Table 1 Effects of γ-actin knockdown on random motility
parameters
Parameters Control siRNA γ-actin siRNA % change
Average cell velocity
(μm/min)
0.53 ± 0.03 0.37 ± 0.03 −30 ± 5 %**
Persistence time (min) 6.3 ± 0.3 8.6 ± 0.6 +36 ± 7 %*
Random motility
coefficient (μm2/min)
0.90 ± 0.05 0.55 ± 0.07 −38 ± 8 %**
At least 25 individual cells were analysed per view field using the persistence
random-walk model [19]. Values are average of four individual experiments ±
SEM. Statistics were calculated by comparing control and γ-actin siRNA-treated
cells: *, p < 0.05; **, p < 0.01.
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increase in the average thickness of actin stress fibres,
which was 0.75 ± 0.15 μm and 1.04 ± 0.17 μm in control
and γ-actin siRNA-treated cells, respectively (Figure 7B;
p < 0.001). This demonstrates that γ-actin knockdown re-
sults in a change in filamentous actin (F-actin) structures
as a result of changing the β- to γ-actin ratio. Control
siRNA-treated cells displayed uniform paxillin staining
with small focal adhesions located throughout the cyto-
plasm and in the lamellipodia. In sharp contrast, γ-actin
siRNA-treated cells showed larger focal adhesions dis-
persed throughout the cell periphery. Quantitative analysis
showed that γ-actin knockdown did not alter the number
of paxillin-containing adhesions but significantly increased
their average size by 76%, from 0.96 ± 0.08 μm2 to 1.67 ±
0.11 μm2 (Figure 7C; p < 0.001). This accumulation of
thick actin stress fibres and large focal adhesions could re-
sult from sustained activation of ROCK signalling [8].
Western blot analysis revealed that γ-actin knockdown
was associated with a 58% increase in phosphorylation of
myosin light chain 2 (Figure 7D-E), thus confirming acti-
vation of the ROCK pathway.
Cytoplasmic γ-actin regulates angiogenesis through
ROCK-dependent and ROCK-independent mechanisms
Pharmacological inhibition of ROCK signalling showed
that the impairment of motility induced by γ-actin
knockdown was entirely dependent upon ROCK activa-
tion (Figure 8A). Indeed, incubation with H-1152 and
Y-27632 inhibitors completely restored the motility of γ-
actin siRNA-treated HMEC-1 cells. Similar results were
obtained with BMH29L cells (Additional file 7: Figure
S6). In contrast with the complete rescue of the γ-actin
knockdown motility phenotype by ROCK inhibitors, the
capacity of γ-actin siRNA-treated cells to form and
maintain vascular networks on Matrigel™ was only par-
tially restored by ROCK inhibition (Figure 8B-D). Incu-
bation of control siRNA-treated HMEC-1 cells with H-
1152 and Y-27362 increased vascular sprouting and
therefore led to the formation of more but significantly
smaller capillary-like tubes, resulting in a marginal
decrease in total vascular surface (4-6% decrease ascompared to control untreated cells). The angiogenic
potential of γ-actin siRNA-treated cells was improved
when ROCK signalling was inhibited but vascular re-
gression was not entirely prevented (Figure 8B). In γ-
actin knockdown HMEC-1 cells, angiogenesis inhibition
was thus reduced from 75 ± 6% in untreated cells to 38
± 8% and 26 ± 8% in cells incubated with H-1152 and Y-
27632, respectively (Figure 8C; p < 0.001). Quantification
of the number of vascular networks formed confirmed
that incubation with H-1152 and Y-27362 increased vas-
cular sprouting (Figure 8D; p < 0.001) but γ-actin knock-
down still resulted in significantly less networks formed
in all conditions. Partial rescue of the angiogenesis sup-
pression induced by γ-actin knockdown was also ob-
served in BMH29L cells as a result of ROCK inhibition
(Additional file 8: Figure S7). Collectively, the results of
our study show that γ-actin plays a key role in the
morphological differentiation of endothelial cells into
vascular networks, through both ROCK-dependent and
ROCK-independent mechanisms.
Discussion
Actin-binding and regulatory proteins have been pro-
posed to represent attractive targets for the development
of innovative anti-angiogenic therapies [22]. However,
the role of the actin cytoskeleton in angiogenesis has not
been completely elucidated. Basic cell biology studies are
crucially needed to map the specific role played by each
component of the actin cytoskeleton in order to find
new ways to target angiogenesis in pathologies such as
cancer and rheumatoid arthritis. Here, we investigated
the cellular distribution and localization of the two cyto-
plasmic isoforms of actin, β and γ, in vascular endothe-
lial cells and performed the first functional analysis of
γ-actin in these cells, revealing a key role for this protein
in angiogenesis.
Co-immunofluorescence staining using newly devel-
oped antibodies directed against β- and γ-actin revealed
a strong colocalization of the two cytoplasmic actin iso-
forms in vascular endothelial cells, albeit some level of
spatial preference. Our findings are in accordance with
the preferential localization of β-actin in radial stress fi-
bres and membrane ruffling and γ-actin in the cortical
microfilament meshwork previously reported in epithe-
lial cells, fibroblasts [7] and more recently in neuroblast-
oma cells [8]. The subcellular localization of β- and
γ-actin expression appears to be mediated by localization
of their respective mRNA [5]. Furthermore, studies have
shown that β- and γ-actin differentially interact with
accessory proteins such as tropomyosins [23] and non-
sarcomeric myosins [24]. These differential interactions
may govern the specific functions of β- and γ-actin, and
therefore contribute to the spatial and temporal regula-
tion of cytoskeletal dynamics.
Figure 7 Effect of γ-actin knockdown on ROCK signalling. (A) Representative photographs of HMEC-1 endothelial cells treated for 72 h with
control (top) or γ-actin siRNA (bottom) and co-stained with phalloidin (left) and anti-paxillin antibody. The merged photographs (right) show
phalloidin in red, paxillin in green and DNA (DAPI) in blue. Inset shows a magnified view of paxillin staining in the lamellipodial region. Scale bar,
20 μm. (B-C) Scatter dot plots showing the thickness of actin stress fibres and the size of paxillin-containing adhesions in HMEC-1 endothelial cells
treated for 72 h with control (o) or γ-actin siRNA (Δ). Bars, means of at least 15 individual cells. (D) Representative immunoblots of HMEC-1 cell
lysates following treatment with control and γ-actin siRNA for 72 h. Membranes were probed with anti-γ-actin, anti-GAPDH (loading control) and
anti-phospho-myosin light chain 2 antibodies. (E) Histogram showing the relative levels of phosphorylated myosin light chain 2 in HMEC-1 cells
following treatment with control (white) and γ-actin siRNA (black) for 72 h. Columns, means of at least four individual experiments; bars, SE.
Statistics were calculated by comparing control siRNA- versus γ-actin siRNA-transfected cells. **, p < 0.01; ***, p < 0.001.
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in vascular endothelial cells without inducing major
cytotoxicity, suggesting that these cells are particularlysensitive to changes in β-actin expression. In contrast,
γ-actin expression could be successfully knocked
down by 50-60% in endothelial cells, indicating an
Figure 8 Effect of ROCK signalling inhibition on γ-actin knockdown-induced vascular regression. (A) Graph showing the percentage of
wound recovery as a function of time for control (black) and γ-actin knockdown (red) HMEC-1 cells, either untreated (left) or treated with ROCK
inhibitors, H-1152 (middle) or Y-27632 (right) at 1 and 10 μM, respectively. Points, means of at least four individual experiments; bars, SE. (B)
Representative photographs of HMEC-1 cells incubated for 8 h on MatrigelTM. Cells were transfected with either control (top) or γ-actin siRNA
(bottom) for 72 h and either untreated (left) or treated with ROCK inhibitors, H-1152 (middle) or Y-27632 (right) at 1 and 10 μM, respectively. Inset,
% of angiogenesis inhibition as compared to untreated control cells. Scale bar, 250 μm. (C-D) Histograms showing the surface occupied by and
the number of vascular networks formed by control and γ-actin siRNA-transfected HMEC-1 cells following treatment with ROCK inhibitors.
Columns, means of at least four individual experiments; bars, SE. Statistics were calculated by comparing the mean surface occupied by vascular
networks and the mean number of vascular networks per view field (at least 10 view fields per condition) for control siRNA- versus γ-actin
siRNA-transfected cells unless indicated otherwise. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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This difference in response to β- and γ-actin knock-
down is consistent with recent studies showing that β-
actin knockout mice are not viable [9] unlike γ-actin
knockout mice, which despite suffering increased mor-
tality and showing progressive hearing loss during
adulthood, are viable [10].Interestingly, γ-actin knockdown almost completely
suppressed the capacity of endothelial cells to maintain
capillary-like structures on Matrigel™. Timelapse videomi-
croscopy analysis revealed that γ-actin was dispensable in
the early steps of the morphological differentiation process
(i.e. vascular sprouting) but required to sustain newly
formed vascular networks. Previous studies have shown
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cadherin, plays a crucial role in angiogenesis – reviewed in
[25-27]. The development of a VE-cadherin knockout
(Cdh5−/−) mouse model thus revealed that this type II
cadherin is dispensable in de novo blood vessel formation
but essential to prevent the regression and ensure the mat-
uration of nascent blood vessels [28,29]. We therefore hy-
pothesized that VE-cadherin may be involved in the
vascular regression induced by γ-actin knockdown. Our
results showed that the expression of VE-cadherin is rap-
idly up-regulated during the morphological differentiation
of endothelial cells, which is consistent with the study by
Prandini et al. demonstrating that VE-cadherin promoter
activity is enhanced during angiogenesis [30]. Further-
more, we found that the up-regulation of VE-cadherin
was impaired in γ-actin siRNA-treated cells, which may
contribute to vascular regression in these cells. This find-
ing is in agreement with a recent study showing that VE-
cadherin is involved in the cessation of endothelial cell
sprouting [31]. Elsewhere, recent studies have shown that
the major receptor involved in angiogenesis, VEGFR-2,
may be in part regulated by the actin cytoskeleton. For
instance, its localization to the plasma membrane has been
shown to be mediated by myosin 1C, an unconventional
motor protein trafficking along actin filaments [32]. In
addition, inhibition of Rho GTPase Rac1 was found to
down-regulate the expression VEGFR-2 [33]. However, we
demonstrated herein that VEGFR-2 expression was up-
regulated in endothelial cells during the angiogenic
process independently of γ-actin expression.
To better understand how γ-actin knockdown im-
paired the angiogenic process, we investigated its impact
on endothelial cell adhesion, chemotaxis and motility.
While partially depleting γ-actin expression did not alter
cell adhesion, it significantly reduced the capacity of
endothelial cells to respond to chemotactic stimuli, ran-
domly explore their microenvironment and colonize a
new area. This result is in line with other studies
demonstrating the crucial role played by the actin cyto-
skeleton in cell locomotion in non-endothelial cells –
reviewed by Le Clainche and Carlier [34]. It is also
consistent with the results recently reported for γ-actin
depleted epithelial cells [7], arguing in favour of a crucial
role of γ-actin in the control of directional motility in
diverse cell types.
We previously reported that γ-actin regulates neuro-
blastoma cell migration by modulating ROCK signalling
pathway [8]. Here, we extended this finding to vascular
endothelial cells. Indeed, γ-actin knockdown was associ-
ated with accumulation of thicker actin stress fibres,
larger focal adhesions and increased phosphorylation of
myosin light chain 2 in endothelial cells, thus strongly
suggesting activation of the ROCK signalling pathway.
Furthermore, incubation with pharmacological inhibitorsof ROCK signalling completely restored the motility
of γ-actin siRNA-treated cells, demonstrating that the
γ-actin knockdown motility phenotype is dependent
upon ROCK activation. In contrast, ROCK inhibitors
only partially rescued the angiogenic potential of γ-actin
knockdown cells, suggesting that γ-actin regulates angio-
genesis through both ROCK-dependent and ROCK-
independent mechanisms.
Interestingly, VE-cadherin engagement has been
shown to activate numerous biochemical pathways that
can affect cell shape and adhesion, including the ROCK
signalling pathway [35-37]. Furthermore, a direct link
was recently reported between actin stress fibres and the
protein complex forming adherens junctions, VE-
cadherin/β-catenin/α-catenin [38,39]. Here we provide
evidence of the reverse relationship since decreasing the
expression of γ-actin partially blocked the required up-
regulation of VE-cadherin expression during morpho-
logical differentiation of endothelial cells. Additional ex-
periments are currently underway to fully decipher the
mechanisms involved in the crosstalk between γ-actin,
ROCK signalling and VE-cadherin, which appears to
play a critical role in the maintenance of newly formed
vascular networks.
Conclusions
Collectively our results demonstrate for the first time
that γ-actin plays a crucial role in angiogenesis through
the regulation of endothelial cell motility and neovessel
maintenance, via ROCK-dependent and -independent
mechanisms. This finding opens potential therapeutic
avenues for the treatment of angiogenesis-related disor-
ders by targeting key factors involved in the γ-actin/VE-
cadherin/ROCK signalling network.
Additional files
Additional file 1: Figure S1. Quantification of β- and γ-actin colocalization.
(A) Scatter dot plot showing the Pearson’s coefficient of individual HMEC-1
cells treated for 72 h with control (o) or γ-actin siRNA (Δ). Bars, mean of three
individual experiments with SE. Statistics were calculated by comparing control
siRNA- versus γ-actin siRNA-transfected cells. ***, p < 0.001. (B) Representative
2-Dimensional histograms (fluorograms) showing a single linear relationship
in high correlating samples (left) and multiple linear relationships in lower
correlating cells (right). This shows that the lower correlation of β-actin and
γ-actin signals in some cells was mostly due to variations in stoichiometry
rather complete segregation of the two isoforms.
Additional file 2: Figure S2. Effect of γ-actin knockdown on the actin
cytoskeleton. Representative photographs of BMH29L endothelial cells
treated for 72 h with control (left) or γ-actin siRNA (right) and stained with
β-actin (top) and γ-actin (middle) antibodies. The merged photographs
(bottom) show β-actin in green, γ-actin in red and DNA (DAPI) in blue.
Scale bar, 20 μm.
Additional file 3: Figure S3. Effect of γ-actin knockdown on the
formation vascular networks on Matrigel™ using a different siRNA
sequence. (A) Representative immunoblots of HMEC-1 cell lysates follow-
ing treatment with control and γ-actin siRNA2 for 72 h. Membranes were
probed with anti-β-actin, anti-γ-actin and anti-GAPDH (loading control)
Pasquier et al. Vascular Cell  (2015) 7:2 Page 15 of 16antibodies. (B) Histogram showing the relative protein expression of γ-
actin as determined by densitometry after normalization with GAPDH
(loading control), following treatment with control (white) and γ-actin
siRNA2 (black) for 72 h. Columns, means of three individual experiments;
bars, SE. Statistics were calculated by comparing γ-actin expression level
in control and γ-actin siRNA2-treated HMEC-1 cells; ***, p < 0.001. (C)
Representative photographs of HMEC-1 cells incubated for 8 h on
Matrigel™ and following treatment with either control (left) or γ-actin
siRNA (bottom) for 72 h. Scale bar, 250 μm. (D) Histogram showing the
surface occupied by vascular networks following treatment with control
(white) and γ-actin siRNA (black) for 72 h. Columns, means of three
individual experiments; bars, SE. Statistics were calculated by comparing
the mean surface occupied by vascular networks per view field (at least
10 view fields per condition) for control and γ-actin siRNA-treated
HMEC-1 cells. ***, p < 0.001.
Additional file 4: Supplementary videos 1–2. Representative
time-lapse videomicroscopy experiments of control siRNA- and
γ-actin siRNA-treated endothelial cells on Matrigel™. BMH29L cells
were seeded on Matrigel™ 72h after transfection with either control
(Video 1) or γ-actin siRNA (Video 2). Photographs were taken every 5
min for 12 h, using the 5X objective of an Axiovert 200M fluorescent
microscope coupled to an AxioCamMR3 camera driven by the
AxioVision 4.7 software.
Additional file 5: Figure S4. Effect of γ-actin knockdown on VE-cadherin
and VEGFR-2 expression at steady state and during the angiogenic process.
(A) Representative immunoblots of HMEC-1 (left) and BMH29L (right) cell
lysates following treatment with control and γ-actin siRNA for 72 h.
Membranes were probed with anti-VEGFR-2, anti-VE-cadherin,
anti-γ-actin and anti-α-tubulin (loading control) antibodies. (B)
Representative immunoblots of HMEC-1 cell lysates obtained at
different time points of the morphological differentiation process on
Matrigel™, following treatment with either control (left) or γ-actin
siRNA (right) for 72 h. Membranes were probed with anti-VEGFR-2,
anti-γ-actin and anti-GAPDH (loading control) antibodies.
Additional file 6: Figure S5. Effect of γ-actin knockdown on the
microtubule network. Representative photographs of HMEC-1 cells
treated for 72 h with control (left) and γ-actin siRNA (right) and stained
with anti-tubulin antibody. Scale bar, 20 μm.
Additional file 7: Figure S6. Effect of ROCK signalling inhibition on γ-
actin knockdown-induced motility inhibition. Representative photographs
of wound healing experiments with control and γ-actin siRNA-transfected
BMH29L cells. Endothelial cells were either untreated (left) or pre-treated
with H-1152 (middle) or Y-27632 (right) at 10 μM for 24 hours and during
the course of the experiment. Broken lines show the position of the initial
cell-free gap (at time 0) and solid lines highlight the position of the
migration edge after 8 h. Inset, % of wound closure.
Additional file 8: Figure S7. Effect of ROCK signalling inhibition on
γ-actin knockdown-induced vascular regression. (A) Representative
photographs of BMH29L cells incubated for 8 h on Matrigel™. Cells were
transfected with either control (top) or γ-actin siRNA (bottom) for 72 h
and either untreated (left) or treated with 10 μM ROCK inhibitors, H-1152
(middle) or Y-27632 (right). Inset, % of angiogenesis inhibition as compared
to untreated control cells. Scale bar, 250 μm. (B) Histogram showing the
surface occupied by vascular networks following treatment with control
(white) and γ-actin siRNA (black) for 72 h. Columns, means of at least four
individual experiments; bars, SE. Statistics were calculated by comparing
the mean surface occupied by vascular networks per view field (at least 10
view fields per condition) for control siRNA- vs γ-actin siRNA-transfected cells
unless indicated otherwise. *, p<0.05; ***, p < 0.001.
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